Detalhe da pesquisa
1.
Local, Quantitative Morphometry of Fibroproliferative Lung Injury Using Laminin.
Am J Respir Cell Mol Biol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593005
2.
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Clin Infect Dis
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376212
3.
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
JAMA
; 329(14): 1170-1182, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039791
4.
Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP.
Int Arch Allergy Immunol
; 182(5): 417-424, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621972
5.
2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.
Arterioscler Thromb Vasc Biol
; 40(2): 309-322, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852222
6.
18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis.
Eur J Nucl Med Mol Imaging
; 45(12): 2190-2200, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978245
7.
Machine Learning-based Analysis of Publications Funded by the National Institutes of Health's Initial COVID-19 Pandemic Response.
Open Forum Infect Dis
; 11(4): ofae156, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659624
8.
Conjugation of IL-33 to Microporous Annealed Particle Scaffolds Enhances Type 2-Like Immune Responses In Vitro and In Vivo.
Adv Healthc Mater
; : e2400249, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648258
9.
Analysis of National Institutes of Health Funding for the COVID-19 Pandemic.
Open Forum Infect Dis
; 11(3): ofae064, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533269
10.
Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.
Open Forum Infect Dis
; 11(2): ofad630, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312212
11.
Distinct Type 1 Immune Networks Underlie the Severity of Restrictive Lung Disease after COVID-19.
bioRxiv
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38617217
12.
A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosis.
bioRxiv
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659897
13.
Local, Quantitative Morphometry of Fibroproliferative Lung Injury using Laminin.
bioRxiv
; 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398271
14.
Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist.
Heliyon
; 9(8): e19226, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664715
15.
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial.
medRxiv
; 2023 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693596
16.
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
Sci Immunol
; 8(82): eadf0348, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821695
17.
COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity.
Front Immunol
; 13: 989556, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189236
18.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.
Open Forum Infect Dis
; 9(8): ofac343, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35959207
19.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
medRxiv
; 2022 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411349
20.
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Microbiol Spectr
; 10(1): e0256021, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196802